Ruihui Xie

2.2k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Ruihui Xie is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruihui Xie has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruihui Xie's work include RNA modifications and cancer (9 papers), RNA Research and Splicing (9 papers) and Cancer-related molecular mechanisms research (7 papers). Ruihui Xie is often cited by papers focused on RNA modifications and cancer (9 papers), RNA Research and Splicing (9 papers) and Cancer-related molecular mechanisms research (7 papers). Ruihui Xie collaborates with scholars based in China, United States and Hong Kong. Ruihui Xie's co-authors include Xu Chen, Tianxin Lin, Jian Huang, Ming Huang, Jinli Han, Ziyue Chen, Qianghua Zhou, Wen Dong, Weibin Xie and Peng Gu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Cancer Research.

In The Last Decade

Ruihui Xie

23 papers receiving 1.3k citations

Hit Papers

NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
    2023 128 citations Ruihui Xie, Liang Cheng et al. Cancer Research profile →

Peers

Ruihui Xie
Gui Ren China
Yonghao Zhan China
Anbang He China
Xiulin Jiang China
Xiuming Liang China
Ryosuke Matsushita Japan
Rufu Chen China
Wenwei Qian China
Gui Ren China
Ruihui Xie
Citations per year, relative to Ruihui Xie Ruihui Xie (= 1×) peers Gui Ren

Countries citing papers authored by Ruihui Xie

Since Specialization
Citations

This map shows the geographic impact of Ruihui Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruihui Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruihui Xie more than expected).

Fields of papers citing papers by Ruihui Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruihui Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruihui Xie. The network helps show where Ruihui Xie may publish in the future.

Co-authorship network of co-authors of Ruihui Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ruihui Xie. A scholar is included among the top collaborators of Ruihui Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruihui Xie. Ruihui Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hao, et al.. (2025). Epidemiology of Early Onset Prostate Cancer: Global Patterns, Risk Factors, and Projections Through 2040. Annals of Surgical Oncology. 32(12). 9421–9431.
2.
Xie, Ruihui, Qianghua Zhou, Weilong Lin, et al.. (2025). An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer. Journal of Translational Medicine. 23(1). 480–480. 1 indexed citations
3.
4.
Cheng, Liang, Junlin Lu, Ming Huang, et al.. (2024). Oncogenic SLC2A11–MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability. SHILAP Revista de lepidopterología. 5(9). e685–e685. 8 indexed citations
5.
He, Haixia, Yanjie Zhang, Yi Li, et al.. (2024). PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer. Advanced Science. 11(42). e2405997–e2405997. 4 indexed citations
6.
Huang, Hao, Shunli Yu, Zean Li, et al.. (2024). Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer. International Journal of Biological Sciences. 20(12). 4635–4653. 9 indexed citations
7.
Xie, Ruihui, Liang Cheng, Ming Huang, et al.. (2023). NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer. Cancer Research. 83(10). 1666–1683. 128 indexed citations breakdown →
8.
Zhou, Qianghua, Xu Chen, Kai Yao, et al.. (2023). TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination. Journal of Experimental & Clinical Cancer Research. 42(1). 195–195. 14 indexed citations
9.
Zhang, Qiang, Sen Liu, Kanghua Xiao, et al.. (2023). ETV4 Mediated Tumor‐Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer (Adv. Sci. 11/2023). Advanced Science. 10(11). 1 indexed citations
10.
Huang, Ming, Wen Dong, Ruihui Xie, et al.. (2022). HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program. Cancer Communications. 42(5). 447–470. 76 indexed citations
11.
Zhao, Chenxi, Ruihui Xie, Qiuhui Qian, et al.. (2022). Triclosan induced zebrafish immunotoxicity by targeting miR-19a and its gene socs3b to activate IL-6/STAT3 signaling pathway. The Science of The Total Environment. 815. 152916–152916. 21 indexed citations
12.
Zhou, Qianghua, Xu Chen, Haixia He, et al.. (2021). WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer. Theranostics. 11(10). 4809–4824. 44 indexed citations
13.
Zhang, Jingtong, Qianghua Zhou, Keji Xie, et al.. (2021). Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 203–203. 57 indexed citations
14.
Xie, Ruihui, Xu Chen, Liang Cheng, et al.. (2020). NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR. Molecular Therapy. 29(1). 291–307. 61 indexed citations
15.
Xie, Ruihui, Xu Chen, Ziyue Chen, et al.. (2019). Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM. Cancer Letters. 449. 31–44. 76 indexed citations
16.
Dong, Wei, Junming Bi, Hongwei Liu, et al.. (2019). Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis. Molecular Cancer. 18(1). 95–95. 135 indexed citations
17.
Chen, Ziyue, Xu Chen, Ruihui Xie, et al.. (2019). DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression. Molecular Therapy. 27(2). 326–341. 113 indexed citations
18.
Gu, Peng, Xu Chen, Ruihui Xie, et al.. (2019). A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer. Molecular Cancer. 18(1). 109–109. 79 indexed citations
19.
Chen, Xu, Ruihui Xie, Peng Gu, et al.. (2018). Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2. Clinical Cancer Research. 25(4). 1389–1403. 180 indexed citations
20.
Gu, Peng, Xu Chen, Ruihui Xie, et al.. (2017). lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5. Molecular Therapy. 25(8). 1959–1973. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gui Ren Breakdown of academic impact, for papers by Yonghao Zhan Breakdown of academic impact, for papers by Anbang He Breakdown of academic impact, for papers by Xiulin Jiang Breakdown of academic impact, for papers by Xiuming Liang Breakdown of academic impact, for papers by Ryosuke Matsushita Breakdown of academic impact, for papers by Rufu Chen Breakdown of academic impact, for papers by Wenwei Qian
Rankless by CCL
2026